Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 6281376, 11 pages
http://dx.doi.org/10.1155/2016/6281376
Research Article

Flavonoids Extraction from Propolis Attenuates Pathological Cardiac Hypertrophy through PI3K/AKT Signaling Pathway

1China-Japan Union Hospital of Jilin University, Changchun 130033, China
2Chinese Traditional Medicine Institute of Ji Lin Province, Changchun 130021, China
3Changchun University of Chinese Medicine, Changchun 130117, China

Received 13 January 2016; Revised 24 March 2016; Accepted 30 March 2016

Academic Editor: Yoshiji Ohta

Copyright © 2016 Guang-wei Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. D. Abel and T. Doenst, “Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy,” Cardiovascular Research, vol. 90, no. 2, pp. 234–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Allwood, R. T. Kinobe, L. Ballantyne et al., “Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice,” Cardiovascular Pathology, vol. 23, no. 4, pp. 231–237, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Anderson, D. Moore, and D. F. Larson, “Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis,” Perfusion, vol. 23, no. 4, pp. 231–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Aoyagi and T. Matsui, “Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure,” Current Pharmaceutical Design, vol. 17, no. 18, pp. 1818–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Benjamin, R. L. Smith, and P. A. Grayburn, “Ischemic and functional mitral regurgitation in heart failure: natural history and treatment,” Current Cardiology Reports, vol. 16, no. 8, p. 517, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. B. C. Bernardo, K. L. Weeks, L. Pretorius, and J. R. McMullen, “Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies,” Pharmacology and Therapeutics, vol. 128, no. 1, pp. 191–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Cook, G. Cole, P. Asaria, R. Jabbour, and D. P. Francis, “The annual global economic burden of heart failure,” International Journal of Cardiology, vol. 171, no. 3, pp. 368–376, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. G. Rosca, B. Tandler, and C. L. Hoppel, “Mitochondria in cardiac hypertrophy and heart failure,” Journal of Molecular and Cellular Cardiology, vol. 55, no. 1, pp. 31–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. de Groot, “Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects,” Dermatitis, vol. 24, no. 6, pp. 263–282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Lim and M. Theodosiou, “Exercise ventilatory parameters for the diagnosis of reactive pulmonary hypertension in patients with heart failure,” Journal of Cardiac Failure, vol. 20, no. 9, pp. 650–657, 2014. View at Publisher · View at Google Scholar
  11. T. A. McKinsey and D. A. Kass, “Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 617–635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Bacharova, H. Chen, E. H. Estes et al., “Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging,” American Journal of Cardiology, vol. 115, no. 4, pp. 515–522, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Prathapan, V. P. Vineetha, and K. G. Raghu, “Protective effect of Boerhaavia diffusa L.against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells,” PLoS ONE, vol. 9, no. 4, Article ID e96220, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. S. Saba, M. Cameli, G. Casalnuovo et al., “Ventricular-vascular coupling in hypertension: methodological considerations and clinical implications,” Journal of Cardiovascular Medicine, vol. 15, no. 11, pp. 773–787, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Swynghedauw and B. Chevalier, “Biological characteristics of the myocardium during the regression of cardiac hypertrophy due to mechanical overload,” Journal of Heart Valve Disease, vol. 4, supplement 2, pp. S154–S159, 1995. View at Google Scholar · View at Scopus
  16. C. Tarin, B. Lavin, M. Gomez, M. Saura, A. Diez-Juan, and C. Zaragoza, “The extracellular matrix metalloproteinase inducer EMMPRIN is a target of nitric oxide in myocardial ischemia/reperfusion,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 387–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Mavri, H. Abramovič, T. Polak et al., “Chemical properties and antioxidant and antimicrobial activities of slovenian propolis,” Chemistry and Biodiversity, vol. 9, no. 8, pp. 1545–1558, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. V. C. Toreti, H. H. Sato, G. M. Pastore, and Y. K. Park, “Recent progress of propolis for its biological and chemical compositions and its botanical origin,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 697390, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. K. Gupta, D. J. DiPette, and S. C. Supowit, “Protective effect of resveratrol against pressure overload-induced heart failure,” Food Science & Nutrition, vol. 2, no. 3, pp. 218–229, 2014. View at Publisher · View at Google Scholar
  20. T. Wang, X. Yu, S. Qu, H. Xu, B. Han, and D. Sui, “Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 121–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Xu, X. Yu, S. Qu, Y. Chen, Z. Wang, and D. Sui, “Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats,” Experimental and Therapeutic Medicine, vol. 7, no. 1, pp. 165–170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Yang, Y. Dong, H. Du, H. Shi, Y. Peng, and X. Li, “Antioxidant compounds from propolis collected in Anhui, China,” Molecules, vol. 16, no. 4, pp. 3444–3455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Yang, X. Cai, J. Liu et al., “CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling,” PLoS ONE, vol. 8, no. 4, Article ID e62373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Sun, Z. Wu, Z. Wang, and H. Zhang, “Effect of ethanol/water solvents on phenolic profiles and antioxidant properties of Beijing propolis extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 595393, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Midorikawa, A. H. Banskota, Y. Tezuka et al., “Liquid chromatography-mass spectrometry analysis of propolis,” Phytochemical Analysis, vol. 12, no. 6, pp. 366–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Pellati, G. Orlandini, D. Pinetti, and S. Benvenuti, “HPLC-DAD and HPLC-ESI-MS/MS methods for metabolite profiling of propolis extracts,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 5, pp. 934–948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Volpi and G. Bergonzini, “Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 42, no. 3, pp. 354–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Y. Oudit, M. A. Crackower, U. Eriksson et al., “Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure,” Circulation, vol. 108, no. 17, pp. 2147–2152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. S. Weng, H. F. Wang, P. Y. Pai et al., “Tanshinone IIA prevents Leu27IGF-II-induced cardiomyocyte hypertrophy mediated by estrogen receptor and subsequent Akt activation,” The American Journal of Chinese Medicine, vol. 43, no. 8, pp. 1567–1591, 2015. View at Publisher · View at Google Scholar
  30. P. Chang, Q. Wang, H. Xu et al., “Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K/p-Akt pathway in spontaneously hypertensive rats,” Biochemical and Biophysical Research Communications, vol. 463, no. 4, pp. 1012–1020, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. T. Horikawa, M. Panneerselvam, Y. Kawaraguchi et al., “Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling,” Journal of the American College of Cardiology, vol. 57, no. 22, pp. 2273–2283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Okawa, H. Horimoto, S. Mieno, Y. Nomura, M. Yoshida, and S. Sasaki, “Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts,” Molecular and Cellular Biochemistry, vol. 248, no. 1-2, pp. 171–177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Heineke and J. D. Molkentin, “Regulation of cardiac hypertrophy by intracellular signalling pathways,” Nature Reviews Molecular Cell Biology, vol. 7, no. 8, pp. 589–600, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Y. Oudit, H. Sun, B.-G. Kerfant, M. A. Crackower, J. M. Penninger, and P. H. Backx, “The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease,” Journal of Molecular and Cellular Cardiology, vol. 37, no. 2, pp. 449–471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. L. C. Cantley, “The phosphoinositide 3-kinase pathway,” Science, vol. 296, no. 5573, pp. 1655–1657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Unzek and G. S. Francis, “Management of heart failure: a brief review and selected update,” Cardiology Clinics, vol. 26, no. 4, pp. 561–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Braunwald, “Heart failure,” JACC: Heart Failure, vol. 1, no. 1, pp. 1–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. R. McMullen and G. L. Jennings, “Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure,” Clinical and Experimental Pharmacology & Physiology, vol. 34, no. 4, pp. 255–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. D. L. Mann, R. Bogaev, and G. D. Buckberg, “Cardiac remodelling and myocardial recovery: lost in translation?” European Journal of Heart Failure, vol. 12, no. 8, pp. 789–796, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Haunstetter and S. Izumo, “Apoptosis: basic mechanisms and implications for cardiovascular disease,” Circulation Research, vol. 82, no. 11, pp. 1111–1129, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Kubota, M. Miyagishima, C. S. Frye et al., “Overexpression of tumor necrosis factor-α activates both anti- and pro-apoptotic pathways in the myocardium,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 7, pp. 1331–1344, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Hang, Z. Huang, S. Jiang et al., “Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1,” Annals of Clinical & Laboratory Science, vol. 36, no. 1, pp. 88–95, 2006. View at Google Scholar · View at Scopus